Thursday, September 21, 2017
News
  News Updated on Thursday, September 21, 2017 10:36:54 AM
India Asia World Sports Business Sci-Tec Health Entertainment Bollywood Video Press Releases Features City News
 
NEWS HOME
INDIA

Neclife Lifesciences receives Korean FDA for 'Cefuroxime Axetil'
New Delhi | Wednesday, Sep 8 2010 IST
 
   COMMENTS   Print this Page   PRINT   SocialTwist Tell-a-Friend  
   
 


 

Pharmaceutical firm NecLife Lifesciences today announced that it has received Korean food and drug administration's (K-FDA) approval for Cefuroxime Axetil (Amorphous).

''We are optimistic about the new market as we believe South Korea is well placed to register substantial growth in coming years. This approval enables us to further augment our position in the cephalosporin market in three major molecules,'' Nectar Lifesciences Chief Executive Officer (CEO) and Director Dinesh Dua said.

The company expects business potential for the approved molecule 'Cefuroxime Axetil (Amorphous)' to the tune of 10 million dollars, he said.

-- (UNI) -- 08DC6.xml

 

Watch News Videos

 

 
TRENDING TOPICS
 
 
 
CITY NEWS
MORE CITIES
INDIA WORLD ASIA
SC to hear Unitech real estate developer...
Sigh of relief for Mumbaikars, as rains ...
Biggest challenge India facing today is ...
Rahul attacks Centre over intolerance, s...
Rohingya Muslims can be misled, exploite...
Bengal Commission for Child Rights files...
More...    
 
 Top Stories
Key Indian equity market indices op... 
Google acquires HTC's Pixel team fo... 
Divisive politics ruining India's r... 
MSE launches Member Activation Driv... 
Biggest challenge India facing toda... 
Sushma Swaraj meets Chinese Foreign... 
HTC to get USD 1.1 Billion from Goo... 
Growing concern in US over threats ...